EurekAlert!

C-Path announces key leadership appointments in neurodegenerative disease research

TUCSON, Ariz., November 7, 2024 — Critical Path Institute® (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine ...
EurekAlert!

C-Path’s Translational Therapeutics Accelerator marks record year with seven BRIDGe awards advancing potential therapies across cancer, infectious disease, neurology and ...

TUCSON, Ariz., September 4, 2025 —Critical Path Institute® (C-Path) announced today that its Translational Therapeutics Accelerator (TRxA) program has completed a record year of funding and mentorship ...
News Medical

C-Path supports innovative ALS, neurodegenerative disease research with new grant

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) announced today a new research grant awarded to Daniela C. Zarnescu, Ph.D., Professor of Cellular and Molecular ...
News Medical

CoRDS and Cure MITO join forces with C-Path to advance research for rare mitochondrial disorders

Critical Path Institute (C-Path) announced today that the Coordination of Rare Diseases based at Sanford Research (CoRDS), in partnership with Cure MITO, will contribute its mitochondrial disorders ...